C
Christoph Seger
Researcher at University of Innsbruck
Publications - 105
Citations - 3592
Christoph Seger is an academic researcher from University of Innsbruck. The author has contributed to research in topics: Medicine & Mass spectrometry. The author has an hindex of 30, co-authored 96 publications receiving 2912 citations. Previous affiliations of Christoph Seger include University of Vienna & University of Graz.
Papers
More filters
Journal ArticleDOI
Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy : Second Consensus Report
Mercè Brunet,Teun van Gelder,Anders Åsberg,Vincent Haufroid,Vincent Haufroid,Dennis A. Hesselink,Loralie J. Langman,Florian Lemaitre,Pierre Marquet,Christoph Seger,Maria Shipkova,Alexander A. Vinks,Alexander A. Vinks,Pierre Wallemacq,Eberhard Wieland,Jean-Baptiste Woillard,Markus J. Barten,Klemens Budde,Helena Colom,Maja Theresa Dieterlen,Laure Elens,Kamisha L. Johnson-Davis,Paweł K. Kunicki,Iain MacPhee,Satohiro Masuda,Binu S. Mathew,Olga Millán,Tomoyuki Mizuno,Tomoyuki Mizuno,Dirk Jan A.R. Moes,Caroline Monchaud,Ofelia Noceti,Tomasz Pawinski,Nicolas Picard,Ron H.N. van Schaik,Claudia Sommerer,Nils Tore Vethe,Brenda C. M. de Winter,Uwe Christians,Stein Bergan +39 more
TL;DR: It is concluded that considerable advances in the different fields of tacrolimus monitoring have been achieved during this last decade, and the Expert Committee concludes that Continued efforts should focus on the opportunities to implement in clinical routine the combination of new standardized PK approaches with PG, and valid biomarkers to further personalize tacolimus therapy and to improve long-term outcomes for treated patients.
Journal ArticleDOI
Pitfalls Associated with the Use of Liquid Chromatography–Tandem Mass Spectrometry in the Clinical Laboratory
Michael Vogeser,Christoph Seger +1 more
TL;DR: LC-MS/MS methods should undergo rigorous and systematic validation before introduction into patient care and can be controlled by sufficient LC separation-based sample workup before MS analysis.
Journal ArticleDOI
A decade of HPLC-MS/MS in the routine clinical laboratory--goals for further developments.
Michael Vogeser,Christoph Seger +1 more
TL;DR: HPLC-MS/MS has the potential to be further developed to a commonly applied high-throughput technique in clinical chemistry, complementary to present standard techniques as photometry and ligand binding methods.
Journal ArticleDOI
Antifungal stilbenoids from Stemona collinsae.
TL;DR: Fifteen new stilbenoids including 11 phenylbenz ofurans, the stemofurans A-K, and four dihydrostilbenes, the stilbostemins A, C, E, and F were isolated and identified from a methanolic extract of Stemona collinsae roots.
Journal ArticleDOI
After another decade: LC-MS/MS became routine in clinical diagnostics.
Christoph Seger,Linda Salzmann +1 more
TL;DR: The instrumentation matured significantly, the applications are well understood, and the in vitro diagnostics (IVD) industry is shaping the market by providing assay kits, certified instruments, andThe first laboratory automated LC-MS/MS instruments as an analytical core.